Key result
Bioreactor-cultured 3D-hiPSC-CT transplantation improves tissue survival and LVEF after MI in rats.
Answers are grounded in this paper and cite their sources.
A rotating wall vessel (RWV) bioreactor was constructed for growing massive functional cardiac constructs to recover the function of a distressed rat heart. Three-dimensional cardiac tissues were engineered by seeding human-induced pluripotent stem cell-derived cardiomyocytes on poly(lactic-co-glycolic acid) fiber sheets (3D-hiPSC-CTs) and cultured in the RWV bioreactor (RWV group) or under static conditions (control group). The tissues were transplanted into a myocardial infarction nude rat model, and cardiac performance was evaluated. In the RWV group, cell viability and contractile and electrical properties significantly improved, mature cardiomyocytes were observed, and mechanical stress-related mediators of mammalian target of rapamycin signaling were upregulated compared with those of the control. Four weeks post-transplantation, tissue survival and left ventricular ejection fraction significantly improved in the RWV group. Hence, dynamic culture in an RWV bioreactor could provide a superior culture environment for improved performance of 3D-hiPSC-CTs, providing a means for functional cardiomyogenesis in myocyte-loss heart failure.
No takes yet. Share an insight, caveat, or question.
Nakazato et al. (2022) studied Myocardial infarction. 3D-hiPSC-CTs cultured in RWV bioreactor vs. 3D-hiPSC-CTs cultured under static conditions was evaluated on Tissue survival and left ventricular ejection fraction. Transplantation of 3D-hiPSC-CTs cultured in a rotating wall vessel bioreactor significantly improved tissue survival and left ventricular ejection fraction at 4 weeks in rats with myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: